Here is IP Think Tank’s weekly selection of top
intellectual property news breaking in the blogosphere and internet.

The biggest news this week was the injunction restraining implementation of the new USPTO Rules. While on a lighter (virtual) note, there’s now a patent and trade mark office on SecondLife…

Please join the discussion by adding your comments on any
of these stories, and please do let me know if you think we’ve missed
something
important, or if there is a source you think should be monitored.

You
can separately subscribe to the IP Thinktank Global week in Review at http://thinkipstrategy.com/subscribe/

Global

• More SecondLife IP litigation (copyright): (Patry Copyright Blog),
• SecondLife patent and trademark office opens: (Impact),
• The unanswered question in intellectual property (IP Think Tank),
• Two big patent securitzations around the corner: (IAM),
• Monetizing IP the (new) IBM way: (IP Think Tank),
• Monsanto’s costly patent strategy mistake: (IP Think Tank),

China

• Exploding the myths about China’s legal system: (China Law Blog),
• GE wins trade secrets and unfair competition battle with Jiuxiang Electrial Technology Co. Ltd over use of information by former employee (Rouse & Co.),
• China enacts amendment to TRIPS allowing
  compulsory patent
  licence system when public health emergencies occur (Rouse & Co.), (IPDragon), (IPKat), (ChinaDaily),
• IP Injunctions on the rise in China (Rouse & Co.),

France

• French implement IP Enforcement Directive: (IPKat),

Germany

• Germany copyright law amended: (Stanford),
• German Federal Patent Court invalidates one of the Lipitor patents: (IP Law360), (Generic Pharmaceuticals),

Hungary

• Hungarian public broadcaster, Magyar Televizio, known affectionately by its acronym MTV, faces challenge from Viacomm’s MTV Musc Channel: (IPKat),

India

• Ranbaxy sues Polish company over registration of ‘ranbaxy.ed’, but in the Delhi High Court…: (Poland-IP law),
• The Biological Diversity Act: (SpicyIP),
• IP and Traditional Medicine: (SpicyIP),
• Internationalised Domain Names and India: (SpicyIP),
• Organization of Pharmaceutical Producers of India, (OPPI) which represents foreign-owned drug firms reiteratee its
  demand for removal of the pre-grant opposition provision from the Indian patent law (citing misuse by generic companies): (livemint),
• Lilly inked a deal with India-based Glenmark Pharmaceuticals to
  acquire rights to a portfolio of TRPV1 antagonist molecules, including a Phase
  II compound, GRC 6211, for osteoarthritic pain: (invivoblog),

Italy

• 4 illegal music file-swappers face fines of 12 million Euro: (IPKat),

South Korea

• Seoul Semiconductor wins appeal for damages and injunction against Itswell: (Semiconductor today),

Poland

• Ranbaxy sues Polish company over registration of ‘ranbaxy.ed’, but in the Delhi High Court…: (Poland-IP law),

• Google wins gmail.com.pl domain name dispute: (Poland IP Law),

Thailand

• Twenty more pharmaceutical compulsory licenses in the Thai pipeline: (Intellectual Property Watch),

United States

• Implementation of the New USPTO Rules delayed by injunction by Judge James C. Cacherisi, of the Eastern District of Virginia: (Patently’O), (IPKat), (Blawg-IT), (I/P Updates), (Patent Baristas), (Chicago IP Litigation Blog), (Patent Docs), (IP Spotlight), (Filewrapper.com), (Promotetheprogress), (IPFactor), (Post-Grant), (Patent Prospector), (IAM), etc etc
• What next for the USPTO Rules?: (PLI), (PatentDocs), (Patent Baristas), (Patently’O),
• Vonage settles patent dispure with Verizon: (IP Law360),
• Celgene and Novartis file extended release Ritalin suit: (IP Law360),
• T-Mobile USA is the latest to settle charges
  that it infringed technology for computerized sales methods held by
  patent-holding company Orion IP LLC: (IP Law360),
• Bayer beats Dr Reddy’s on Avelox (moxifloxacin): (OrangeBookBlog), (Generic Pharmaceuticals),
• Martek obtains permanent injunction agains Lonza, Nutrinova: (Maryland IP Law Blog),
• Boston Scientific Corp. liable for infringing on Cordis Corp.’s stent
  patents, in a ruling that comes at the end of a five-year battle
  between the medical device makers (IPLaw 360),
• Wi-LAN, a Canadian licensing company has targeted 22 of the world’s largest
  computer chip manufacturers, equipment vendors and electronics
  retailers for allegedly violating patents related to wireless computer
  connections: (Philip Brooks), (IP Law 360), (Patent Troll Tracker), (ZDNet), (Peter Zura),
• Dexcel Pharma Technologies Ltd. has reached a settlement with AstraZeneca in a patent dispute over Prilosec OTC: (IP Law 360), (Generic Pharmaceuticals),
• Cobalt Pharmaceuticals Inc. is seeking U.S. regulatory approval to make
  and sell a generic version of Astrazeneca PLC’s cholesterol drug Crestor: (IP Law 360),
• Apple seeks revocation of Burst’s Media patents: (IP Law 360),
• Acer countersues Hewlett Packard for patent infringement: (IP Law 360),
• AT&T wins reversal of $156m wilful infringement verdict: (IP Law360),
• Sandisk has filed three law-suits against a total of 25 defendants for infringing their patents for flash memory: (IPFactor), (Philip Brooks),
• Par Pharmaceuticals appetite stimulant patent (for liquids containing megestrol acetate) still invalid as lacking Enablement under 112 on appeal in Roxane litigation: (IP Law360), (OrangeBook Blog), (IPBiz), (Generic Pharmaceuticals),
• DUSA and River’s Edge settle acne treatment patent suit: (IP Law360),
• Five leading
  commercial copyright owners (CBS (CBS), Disney (DIS), Fox Entertainment (NWS), NBC Universal (GE) and
  Viacom (VIA)) collaborated with four leading User-generated content sites
  (Dailymotion, Soapbox on MSN Video (MSFT), MySpace and Veoh.com) to establish a new
  set of User Generated Content Principles: (Seeking alpha)